| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |